MayTech Global Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-150,400
Closed -$10.8M 75
2022
Q1
$10.8M Buy
150,400
+39,000
+35% +$2.81M 2.49% 16
2021
Q4
$10.2M Sell
111,400
-22,776
-17% -$2.72M 2.06% 15
2021
Q3
$17M Buy
134,176
+2,444
+2% +$356K 3.52% 14
2021
Q2
$21.9M Buy
131,732
+23,952
+22% +$3.88M 4.58% 10
2021
Q1
$19.6M Buy
107,780
+651
+0.6% +$151K 4.71% 10
2020
Q4
$21.4M Buy
107,129
+30,732
+40% +$6.25M 5.09% 8
2020
Q3
$16.7M Buy
76,397
+3,156
+4% +$668K 4.47% 10
2020
Q2
$14M Buy
73,241
+486
+0.7% +$85.2K 4.39% 10
2020
Q1
$11.3M Buy
72,755
+469
+0.6% +$54.6K 5.15% 8
2019
Q4
$6.05M Buy
72,286
+172
+0.2% +$13.1K 2.63% 16
2019
Q3
$4.88M Buy
72,114
+5,964
+9% +$393K 2.41% 16
2019
Q2
$4.39M Buy
66,150
+2,123
+3% +$124K 2.2% 18
2019
Q1
$3.56M Buy
+64,027
New +$3.91M 1.88% 21

Other funds holding TDOC

MayTech Global Investments's TDOC Position: Q2 2022 in Review

MayTech Global Investments sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 150,400 shares — an estimated $10.8M sold.

MayTech Global Investments first reported a position in TDOC in Q1 2019 and held it in 13 quarters. The position peaked at $21.9M in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • MayTech Global Investments reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • MayTech Global Investments sold 150,400 Teladoc Health shares in Q2 2022, an estimated $10.8M.
  • MayTech Global Investments first reported a position in Teladoc Health in Q1 2019 and held it in 13 quarters.
  • MayTech Global Investments's Teladoc Health position peaked at $21.9M in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on MayTech Global Investments's 13F filing for Q2 2022, filed 12 Aug 2022.